<DOC>
	<DOC>NCT02491112</DOC>
	<brief_summary>The objective of this study is to evaluate the safety and efficacy of Luliconazole Cream 1% when applied topically for 7 days in pediatric subjects 2 years to 17 years of age with tinea corporis.</brief_summary>
	<brief_title>A Randomized Study Evaluating the Safety and Efficacy of Luliconazole Cream in Pediatric Subjects With Tinea Corporis</brief_title>
	<detailed_description />
	<mesh_term>Tinea</mesh_term>
	<criteria>1. Subjects (or legal guardian) with the ability and willingness to sign a written informed consent and/or assent (age appropriate). 2. Subjects of either gender must be 2 years to &lt; 18 years of age (2 to 17 years of age, inclusive). 3. Subjects with a clinical diagnosis of tinea corporis characterized by clinical evidence of a tinea infection 4. Subjects must be in good general health and free of any disease that in the Investigator's opinion might interfere with the study evaluations. 1. Subjects with active atopic or contact dermatitis in the treatment area. 2. Subjects with severe dermatophytoses, mucocutaneous candidiasis, or bacterial skin infection. 3. Female subjects who are pregnant and/or nursing or planning a pregnancy during the course of the trial. 4. Subjects who are immunocompromised (due to disease, e.g., HIV or medications).</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>